Literature DB >> 14966365

N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats.

Bang Gee Hsu1, Fwu Lin Yang, Ru Ping Lee, Tai Chu Peng, Horng Jyh Harn, Hsing I Chen.   

Abstract

Lipopolysaccharide is strongly associated with septic shock, leading to multiple organ failure. It can activate monocytes and macrophages to release proinflammatory mediators such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and nitric oxide (NO). The present experiments were designed to induce endotoxin shock by an intravenous injection of Klebsiella pneumoniae lipopolysaccharide (LPS, 10 mg/kg) in conscious rats. Arterial pressure and heart rate (HR) were continuously monitored for 48 h after LPS administration. N-Acetylcysteine was used to study its effects on organ damage. Biochemical substances were measured to reflect organ functions. Biochemical factors included blood urea nitrogen (BUN), creatinine (Cre), lactic dehydrogenase (LDH), creatine phosphokinase (CPK), aspartate transferase (GOT), alanine transferase (GPT), TNF-alpha, IL-1 beta, methyl guanidine (MG), and nitrites/nitrates. LPS caused significant increases in blood BUN, Cre, LDH, CPK, GOT, GPT, TNF-alpha, IL-1 beta, MG levels, and HR, as well as a decrease in mean arterial pressure and an elevation of nitrites/nitrates. N-Acetylcysteine suppressed the release of TNF-alpha, IL-1 beta, and MG, but enhanced NO production. These actions ameliorate LPS-induced organ damage in conscious rats. The beneficial effects may suggest a potential chemopreventive effect of this compound in sepsis prevention and treatment. Copyright 2004 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966365     DOI: 10.1007/bf02256558

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  8 in total

1.  Cardiac function and circulating cytokines after endotoxin exposure in neonatal mice.

Authors:  Rupak Mukherjee; Tim C McQuinn; Melissa A Dugan; J Philip Saul; Francis G Spinale
Journal:  Pediatr Res       Date:  2010-11       Impact factor: 3.756

2.  The relationship between N-acetylcysteine, hyperbaric oxygen, and inflammation in a rat model of acetaminophen-induced nephrotoxicity.

Authors:  Hakan Cermik; Mine Yavuz Taslipinar; Ibrahim Aydin; Mehmet Agilli; Fevzi Nuri Aydin; Fatma Ucar; Bilal Firat Alp; Mehmet Toygar; Esin Ozkan; Ertan Altayli; Tuncer Cayci
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

Review 3.  Acute respiratory distress syndrome and lung injury: Pathogenetic mechanism and therapeutic implication.

Authors:  Chain-Fa Su; Shang Jyh Kao; Hsing I Chen
Journal:  World J Crit Care Med       Date:  2012-04-04

4.  Acute lung injury and acute respiratory distress syndrome: experimental and clinical investigations.

Authors:  Hsing I Chen
Journal:  J Geriatr Cardiol       Date:  2011-03       Impact factor: 3.327

Review 5.  N-acetylcysteine for sepsis and systemic inflammatory response in adults.

Authors:  Tamas Szakmany; Balázs Hauser; Peter Radermacher
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

6.  Linagliptin Protects against Endotoxin-Induced Acute Kidney Injury in Rats by Decreasing Inflammatory Cytokines and Reactive Oxygen Species.

Authors:  Tsung-Jui Wu; Yi-Jen Hsieh; Chia-Wen Lu; Chung-Jen Lee; Bang-Gee Hsu
Journal:  Int J Mol Sci       Date:  2021-10-17       Impact factor: 5.923

Review 7.  Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs.

Authors:  Irene Ramos; Ana Fernandez-Sesma
Journal:  Front Immunol       Date:  2015-07-20       Impact factor: 7.561

8.  Effects of N-acetylcysteine (NAC) supplementation in resuscitation fluids on renal microcirculatory oxygenation, inflammation, and function in a rat model of endotoxemia.

Authors:  Bulent Ergin; Philippe Guerci; Lara Zafrani; Frank Nocken; Asli Kandil; Ebru Gurel-Gurevin; Cihan Demirci-Tansel; Can Ince
Journal:  Intensive Care Med Exp       Date:  2016-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.